Acceleration of neutrophil precursors' maturation and immunostimulation of CD3 +, CD4 + lymphocytes by stanozolol in mice

Journal of Steroid Biochemistry and Molecular Biology

Volumn 129, Issue 3-5, 2012, Pages 172-178

  Inamdar, Laxmi S ^a   Jayamma, Y ^b  

^a KARNATAK UNIVERSITY   (India)

^b JSS College   (India)

Author keywords

CD3 + and CD4 + lymphocytes; Granulopoiesis; Lipoprotein profile; Mice; Stanozolol

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STANOZOLOL; TRIACYLGLYCEROL;

ACCELERATION; ANIMAL CELL; ARTICLE; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; GRANULOPOIESIS; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PHYSICAL PERFORMANCE; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANABOLIC AGENTS; ANIMALS; ANTIGENS, CD3; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRANULOCYTES; LIPIDS; LIPOPROTEINS; LYMPHOCYTE COUNT; LYMPHOCYTES; MICE; STANOZOLOL;

MUS;

EID: 84858297790     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.11.008     Document Type: Article

References (57)

1. F. Daniel, D.G. Rao, and C.J. Tyrrell A pilot study of stanozolol for advanced breast carcinoma Cancer 67 1991 2966 2968
2. K. Doney, M. Pepe, R. Storb, F. Bryant, C. Anasetti, F.R. Appelbaum, C.D. Buckner, J. Sanders, J. Singer, K. Sullivan, P. Weiden, and J.A. Hansen Immunosuppressive therapy of aplastic anemia. Results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone Blood 79 1992 2566 2571
3. A. Bacigalupo, M. Chaple, J. Hows, M. Van Lint, S. McCann, D. Milligan, J. Chessells, A. Goldstone, J. Ottolander, E. Van't Veer, B. Comotti, P. Coser, G. Broccia, A. Bosi, A. Locasciulli, L. Catalano, R. Battista, W. Arcese, M. Carotenuto, A. Marmont, and E.C.G. Smith Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party Br. J. Haematol. 83 1993 145 151 (Pubitemid 23030186)
4. C.D. Kochakian Anabolic-androgenic steroids: a historical perspective and definition C.E. Yesalis, Anabolic Steroids in Sport and Exercise 1993 Human Kinetics Publishers, Inc. Champaign, IL 3 33
5. I. Zofkova, S. Rojdmark, and R.L. Kancheva Stanozolol - an anabolic steroid that does not influence parathyroid hormone response to hypercalcemia in postmenopausal women Calcif. Tissue Int. 54 1994 521 522 (Pubitemid 24148217)
6. + ratio after one month of treatment with stanozolol in postmenopausal women Steroids 60 1995 430 433
7. S. Basaria, J.T. Wahlstrom, and A.S. Dobs Anabolic-androgenic steroid therapy in the treatment of chronic diseases J. Clin. Endocrinol. Metab. 86 2001 5108 5117 (Pubitemid 33070222)
8. S.E. Lukas Current perspectives on anabolic androgenic steroid abuse Trends Pharmacol. Sci. 14 1993 61 68 (Pubitemid 23049342)
9. M.W. Kibble, and M.B. Ross Adverse effects of anabolic steroids in athletes Clin. Pharm. 6 1987 686 692 (Pubitemid 17152547)
10. J.D. Wilson Androgen abuse by athletes Endocr. Rev. 9 1988 181 199
11. G. Glazer Atherogenic effects of anabolic steroids on serum lipid levels: a literature review Arch. Intern. Med. 151 1991 1925 1933
12. L.L. Bausserman, A.L. Saritelli, and P.N. Herbert Effects of short-term stanozolol administration on serum lipoproteins in hepatic lipase deficiency Metabolism 46 9 1997 992 996 (Pubitemid 27371813)
13. M. Parssinen, and T. Seppala Steroid use and long-term health risks in former athletes Sports Med. 32 2002 83 94 (Pubitemid 34161069)
14. F. Hartgens, and H. Kuipers Effects of androgenic-anabolic steroids in athletes Sports Med. 34 8 2004 513 554 (Pubitemid 38981844)
15. R.C. Hall Abuse of supraphysiologic doses of anabolic steroids South Med. J. 98 2005 550 555 (Pubitemid 40696447)
16. C. Maravelias, A. Dona, M. Stefanidou, and C. Spiliopoulou Adverse effects of anabolic steroids in athletes. A constant threat Toxicol. Lett. 158 2005 167 175 (Pubitemid 41074813)
17. M. Hashemi, F. Bayat, R. Heidari, R. Basiratnia, and Y. Kiyani Endothelial function in male body builders taking anabolic androgenic steroids J. Res. Med. Sci. 10 6 2005 371 376 (Pubitemid 41824495)
18. J. Frohlich, T. Kullmer, A. Urhausen, R. Bergmann, and W. Kindermann Lipid profile of body builders with and without self administration of anabolic steroids Eur. J. Appl. Physiol. Occup. Physiol. 59 1-2 2006 98 103
19. K. Fontana, H.C.F. Oliveira, M.B. Leonardo, C.A. Mandarim-de-Lacerda, and M.A. da Cruz-Hofling Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training Int. J. Exp. Pathol. 89 5 2008 358 366
20. R. Franssen, M.E. Visser, J.A. Kuivenhoven, J.J.P. Kastelein, G.M. Dallinga-Thie, and S.G. Erik Stroes Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target Future Med. - Future Lipidol. 3 4 2008 385 397
21. C.M. Kuhn Anabolic steroids Recent Prog. Horm. Res. 57 2002 411 434
22. Y. Jayamma, and L.S. Inamdar Effect of anabolic-androgenic steroid (stanozolol) on folliculogenesis, granulopoiesis and lipid profile in female mice International Symposium on "Current Trends in Endocrine and Reproductive Health" 2011 69
23. R.H. Strauss, and C.E. Yesalis Additional effects of anabolic steroids on women C.E. Yesalis, Anabolic Steroids in Sport and Exercise 1993 Human Kinetics Publishers, Inc. Champaign, IL 151 160
24. A.D. Mooradian, J.E. Morley, and S.G. Korenman Biological actions of androgens Endocr. Rev. 8 1987 1 28
25. S. Marshall-Gradisnik, R. Green, E.W. Brenu, and R.P. Weatherby Anabolic androgenic steroids effects on the immune system: a review Cent. Eur. J. Biol. 4 1 2009 19 33
26. N.T. Shahidi Androgens and erythropoiesis N. Engl. J. Med. 289 1973 72 80
27. P.D. Thompson, E.M. Cullinane, S.P. Sady, C. Chenevert, A.L. Saritelli, M.A. Sady, and P.N. Herbert Contrasting effects of testosterone and stanozolol on serum lipoprotein levels JAMA 261 8 1989 1165 1168 (Pubitemid 19062451)
28. F.H. Bronson, and C.M. Matherne Exposure to anabolic-androgenic steroids shortens life span of male mice Med. Sci. Sports Exerc. 29 1997 615 619 (Pubitemid 27193747)
29. H.M. Taggart, D. Applebaum-Bowden, S. Haffner, G.R. Warnick, M.C. Cheung, and J.J. Albers Reduction in high density lipoproteins by anabolic-steroid (stanazolol) therapy for postmenopausal osteoporosis Metabolism 31 1982 1147 1152 (Pubitemid 13233919)
30. M. Alen, P. Rahkila, and J. Marniemi Serum lipids in power athletes self-administering testosterone and anabolic steroids Int. J. Sports Med. 6 3 1985 139 144 (Pubitemid 15072088)
31. S.M. Haffner, R.S. Kushwaha, D.M. Foster, D. Applebaum-Bowden, and W.R. Hazzard Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy Metabolism 32 4 1983 413 420 (Pubitemid 13083599)
32. M. Alen, and P. Rahkila Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor Int. J. Sports Med. 5 1984 341 342 (Pubitemid 15219939)
33. O.L. Webb, P.M. Laskarzewski, and C.J. Glueck Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids Metabolism 33 1984 971 975 (Pubitemid 15210828)
34. C. Mewis, I. Spyridopoulos, V. Kuhlkamp, and L. Seipel Manifestation of severe coronary heart disease after anabolic drug abuse Clin. Cardiol. 19 1996 153 155 (Pubitemid 26317722)
35. G.J. Miller, and N.E. Miller Plasma high density lipoprotein concentration and development of ischaemic heart disease Lancet 1 1975 16 20
36. O. Mjos, D. Thelle, and O. Forde Family study of high density lipoprotein cholesterol. Relation to age and sex. The Tromso heart study Acta Med. Scand. 201 1977 323 329 (Pubitemid 8076410)
37. A.E. Doyle, N.B. Pinkers, and J. Green The use of oxandrolone in hyperlipidaemia Med. J. Aust. 1 1974 127 129
38. R.D. Dickerman, W.J. McConathy, and N.Y. Zachariah Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk J. Cardiovasc. Risk 4 1997 363 366 (Pubitemid 28078679)
39. W.B. Malarkey, R.H. Strauss, D.J. Leizman, M. Liggett, and L.M. Demers Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids Am. J. Obstet. Gynecol. 165 1991 1385 1390
40. 1, receptor expression in CD1 mice Curr. Pharm. Biotechnol. 12 2011 275 284
41. P.C. Brum, N.P. Rolim, A.V. Bacurau, and A. Medeiros Neurohumoral activation in heart failure: the role of adrenergic receptors An. Acad. Bras. Cienc. 78 3 2006 485 503 (Pubitemid 44371940)
42. R. Alexanian Erythropoietin and erythropoiesis in anemic man following androgens Blood 33 1969 564
43. R.D. Levere, A. Kappas, and S. Granick Stimulation of hemoglobin synthesis in chick blastoderm by certain 5 beta androstane and 5 beta pregnane steroids Proc. Natl. Acad. Sci. U. S. A. 58 1967 985
44. T.F. Necheles, and U.S. Rai Studies on the control of hemoglobin synthesis. The in vitro stimulating effect of 5-beta-H steroid metabolite on heme formation in human bone marrow cells Blood 34 1969 380
45. K.B. Udupa, and K.R. Reissmann Acceleration of granulopoietic recovery by androgenic steroids in mice made neutropenic by cytotoxic drugs Cancer Res. 34 1974 2517 2520
46. K.B. Udupa, and K.R. Reissmann Stimulation of granulopoiesis by androgens without concomitant increase in the serum level of colony stimulating factor Exp. Hematol. 3 1975 26 31
47. N. D'Alessandro, N. Gebbia, F. Biondo, L. Campio, G. Leto, F. Tumminello, and L. Rausa Haemopoietic effects of 7 alpha, 17 beta dimethyltestosterone Pharmacol. Res. Commun. 11 1979 81 94 (Pubitemid 9141162)
48. V. Rochira, L. Zirilli, B. Madeo, L. Maffei, and C. Carani Testosterone action on erythropoiesis does not require its aromatization, to estrogen: insights from the testosterone and estrogen treatment of two aromatase-deficient men J. Steroid Biochem. Mol. Biol. 113 3-5 2009 189 194
49. S. Shahani, M. Braga-Basaria, M. Maggio, and S. Basaria Androgens and erythropoiesis: past and present J. Endocrinol. Invest. 32 8 2009 704 716
50. P. Deschaux, J.C. Paucod, and D. Ardail Interaction between thymosin, testosterone and estradiol on natural killer cell activity in mice Tohoku J. Exp. Med. 136 1982 367 372
51. H. Fujii, Y. Nawa, H. Tsuchiya, K. Matsuno, T. Fukumoto, and S. Fukuda Effect of a single administration of testosterone on the immune response and lymphoid tissues in mice Cell. Immunol. 20 1975 315 326
52. C.L. Mendenhall, C.J. Grossman, G.A. Roselle, Z. Hertelendy, S.J. Ghosn, and K. Lamping Anabolic steroid effects on immune function: differences between analogues J. Steroid Biochem. Mol. Biol. 37 1990 71 76 (Pubitemid 20385638)
53. T.K. Hughes, E. Fulep, T. Juelich, E.M. Smith, and G.J. Stanton Modulation of immune responses by anabolic androgenic steroids Int. J. Immunopharmacol. 17 1995 857 863
54. P. Tai, J. Wang, H. Jin, X. Song, J. Yan, Y. Kang, L. Zhao, X. An, X. Du, X. Chen, S. Wang, G. Xia, and B. Wang Induction of regulatory T cells by physiological level estrogen J. Cell. Physiol. 214 2 2008 456 464 (Pubitemid 350309002)
55. G. Yao, J. Liang, X. Han, and Y. Hou In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen Int. Immunopharmacol. 3 13-14 2003 1853 1860 (Pubitemid 37421268)
56. T. Saartok, E. Dahlberg, and J.A. Gustafsson Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate as well as to sex hormone-binding globulin Endocrinology 114 6 1984 2100 2106 (Pubitemid 14120261)
57. E.W. Brenu, L. Mc Naughton, and S.M. Marshall-Gradisnik Is there a potential immune dysfunction with anabolic androgenic steroid use? A review Mini Rev. Med. Chem. 11 2011 438 445